Patents by Inventor Bob Kane

Bob Kane has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10814036
    Abstract: Methods for the ex vivo modification of the surfaces of viable tissue result in tissue modifications that are stable and/or result in the controlled release of active compounds, and are expected to provide effective protection for transplanted tissue subsequent to transplant.
    Type: Grant
    Filed: November 7, 2017
    Date of Patent: October 27, 2020
    Assignee: BAYLOR UNIVERSITY
    Inventors: Bob Kane, Babatope Akinbobuyi, Charles Chang, Bashoo Naziruddin
  • Publication number: 20180177918
    Abstract: Methods for the ex vivo modification of the surfaces of viable tissue result in tissue modifications that are stable and/or result in the controlled release of active compounds, and are expected to provide effective protection for transplanted tissue subsequent to transplant.
    Type: Application
    Filed: November 7, 2017
    Publication date: June 28, 2018
    Inventors: Bob Kane, Babatope Akinbobuyi, Charles Chang, Bashoo Naziruddin
  • Publication number: 20170095573
    Abstract: Described herein are therapeutic approaches with immune modifiers of the Th2 pathway for the treatment of allergic and inflammatory diseases. Aspects of the disclosure relate to methods for decreasing Th2-type cell responses in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an anti-Dectin-1 antibody or antigen binding fragment thereof operatively linked to a TLR agonist.
    Type: Application
    Filed: June 2, 2015
    Publication date: April 6, 2017
    Inventors: SangKon OH, Bob Kane, Gerard Zurawski